NCT07237256
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07237256
Title Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib (NoLEEta)
Acronym NoLEEta
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.